Brind.

Dana T. Aftab was appointed Executive Vice President, R&D at Exelixis on August 30, 2025.

1 report, 1 independent Updated Aug 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Dana T. Aftab was appointed Executive Vice President, R&D at Exelixis on August 30, 2025.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • Exelixis

    American biotechnology company

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Business WireExelixis Announces Appointment of Dana T. Aftab, Ph.D. as Executive Vice President, Research and Development – Dr. Aftab has served for over 25 years at Exelixis and has been instrumental in driving